Earnings Call · Q3 FY2024·2024-11-12

Q3 24EPS +22.73%·Rev n/aQ2 24EPS -100.00%*·Rev n/aQ1 24EPS +19.50%·Rev n/aQ4 23EPS -21.95%·Rev n/a⚠ consensus missing

Longeveron Inc. LGVN

Derek Cole — Chief Financial Officer

Wa'el Hashad — Chief Executive Officer

Joshua Hare — Chief Medical Officer

Nataliya Agafonova — Chief Scientific Officer

Lisa Locklear — Chief Financial Officer

+6.0%1d on move date+6.3% vs SPY3d−4.1%5d−11.1%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LGVN calls or request research access.

More LGVN calls Browse calls Request research access